GRB2 and neoplasm: Together, these results provide a platform for antigenic target identification using tumor-isolated B cells and protein arrays, and reveal CCDC155, PDP2 and GRB2 as the tumor-expressed target antigens recognized by Ab36, Ab73 and Ab89, respectively.